by Michael Roub | Sep 21, 2026 | Healthcare, M&A Strategy
You can spend a year building toward a sale and watch it come apart weeks before closing. Healthcare deals fall through more often than most owners expect, and the collapse rarely happens early. It shows up late, after the letter of intent, once diligence turns up...
by Michael Roub | Sep 14, 2026 | Healthcare, M&A Strategy
When you decide to sell, the question that keeps you up at night is not only “what is my practice worth?” It is “who will I hand it to?” The buyer you pick shapes your price, your control, and the role you play once the ink dries. Buyer type...
by Michael Roub | Sep 1, 2026 | Exit Planning, Healthcare, M&A Strategy
Choosing the wrong advisor for your healthcare transaction is one of the most expensive mistakes you can make before a deal even starts. You might leave money on the table, lose leverage with buyers, or spend months in a process that goes nowhere. A business broker...
by Michael Roub | Aug 24, 2026 | Exit Planning, Healthcare, M&A Strategy
Most healthcare owners think about valuation in terms of revenue or a multiple they heard at a conference. Buyers think differently. Understanding that gap and closing it before you go to market is one of the most consequential things you can do to protect your...
by Michael Roub | Jun 22, 2026 | M&A Strategy
Acquiring a healthcare business is one of the highest-stakes decisions a leader or investor can make. The sector carries unique regulatory, operational, and financial complexity that can turn a promising deal into a costly mistake if the process lacks discipline....
by Michael Roub | May 22, 2026 | M&A Strategy
Most healthcare acquisitions don’t fail at closing. They fail in the months afterward, when gaps missed during due diligence become operational and financial problems you now own. A rigorous due diligence process is how you close with confidence, not regret. The...
